The package covers railways, critical minerals, finance and technology, with major US firms involved. Uzbek President ...

CNBC’s “Squawk on the Street” team discusses SpaceX's latest earnings report and what it would mean for markets if SpaceX ...

Q3 results highlighted continued growth in Vyvgart sales, while its acquisition of Forte Biosciences broadened the company's late-stage pipeline ahead of a potentially important phase 3 readout for ...

Fintel reports that on 22 October 2026, Oppenheimer initiated coverage of Kratos Defense & Security Solutions (XTRA:WF5A) with a Outperform recommendation. Kratos Defense & Security Solutions, Inc., ...

Learn more Amgen (AMGN) has an average rating of hold and mean price target of $403.61, according to analysts polled by FactSet.

Morgan Stanley increased its shipment forecasts citing confidence in Bloom Energy’s ability to scale production and convert ...

Atlassian (TEAM) is benefiting from a range of factors heading into its first quarter fiscal 2027 earnings report, as Oppenheimer expects the Australian-based enterprise software firm to surpass ...

Neither a scholar nor a scientist, someone like him shouldn’t be in charge of the future of humanity.

RNAi specialist Alnylam Pharmaceuticals will advance the Huntington’s disease drug brezosiran into a placebo-controlled study ...

Fastly's partnerships with Jio Platforms and Comcast, plus new AI products, position it well in expanding global and AI ...

Zoom Communications ( ZM) was in focus on Wednesday as Oppenheimer upgraded the enterprise software firm to Outperform from Perform with a $130 price target.

Mercilessly bleak war movies like Full Metal Jacket, Come and See, and Paths of Glory rank among the most hopeless in the ...